Compare Koninklijke Philips NV (PHG) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Tesla, Inc. — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Tesla, Inc. trades at $359.31 (market cap $1.42T). The key difference: Tesla, Inc. is far larger — about 54.8× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays a 3.81% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| PHG | TSLA | |
|---|---|---|
Market Cap | $25.89B | $1.42T |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $489.88 |
52-Week Low | $25.02 | $302.63 |
Enterprise Value | $32.18B | $1.39T |
Dividend Yield | 3.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Tesla's stock trades at $374.13, up 1.23% on the day, amid mixed technical signals with a bearish moving average trend but oversold RSI. Fundamentally, the company shows robust revenue near $95 billion for 2025 but faces margin compression, with net income down to $3.79 billion and elevated valuation ratios like a P/E of 347.64. Recent news highlights regulatory approval for self-driving software in Europe and a strategic pivot toward AI and robotics, offset by delivery misses and competitive pressures.
The outlook for Tesla hinges on execution in autonomous driving and energy segments, offering growth potential, but high valuation and margin risks warrant caution. Analyst consensus is divided with a $409.26 price target, reflecting optimism for innovation against near-term operational challenges and stock volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
